Alpiniaterpene A exhibits significant anti-inflammatory activity by inhibiting the production of nitric oxide (NO) in lipopolysaccharide (LPS)-stimulated microglial cells. This property makes it a candidate for research into neurodegenerative diseases where neuroinflammation plays a key role, such as Alzheimer's and Parkinson’s disease. It also shows moderate cytotoxic effects against certain cancer cell lines, suggesting potential as a lead compound in anticancer drug development. Additionally, due to its terpenoid structure, it may contribute to the plant’s defense mechanisms, which could inspire applications in natural pesticide formulations. Research remains primarily in the preclinical stage, focusing on its biological activity and mechanism of action.